Knowledge, Attitude and Practice of Physicians Regarding Screening of Colorectal Cancer in Qatar: A Cross-Sectional Survey.

Middle East bowel cancer doctors residents screening

Journal

Advances in medical education and practice
ISSN: 1179-7258
Titre abrégé: Adv Med Educ Pract
Pays: New Zealand
ID NLM: 101562700

Informations de publication

Date de publication:
2020
Historique:
received: 30 06 2020
accepted: 29 09 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

The aim of this study was to evaluate the rate of internal medicine residents' and faculties' (specialists and consultants) compliance to colorectal cancer screening in Hamad Medical Corporation (Doha, Qatar) and to identify barriers as well as facilitators that will assist in drawing up changes that would enhance physician-related cancer screening. A cross-sectional web-based survey was distributed among internal medicine physicians at three component hospitals of Hamad Medical Corporation (HMC); focusing on knowledge and practice of colorectal cancer screening, its barriers and facilitators. Chi-square and The response rate for the survey was 91% and over 75% of the survey respondents were post-graduate trainees. The majority (90.6%) of the physicians (n=144) mentioned that they would recommend colorectal cancer screening for their asymptomatic patients, though trainees tend to choose the correct modality of screening compared to the consultants, 86.21% vs 40.74%. Only 43.4% of the survey participants always to usually recommend screening to their patients in their clinics while only 29.4% do so for their inpatients. Even though there was no statistically significant difference among the frequency of outpatient colorectal cancer screening among trainees, specialists or consultants ( While the attitude towards colorectal cancer screening is positive, the actual practice of recommendation is sub-optimal. Further initiatives are required to facilitate awareness and compliance to colorectal cancer screening.

Identifiants

pubmed: 33192117
doi: 10.2147/AMEP.S268315
pii: 268315
pmc: PMC7657024
doi:

Types de publication

Journal Article

Langues

eng

Pagination

843-850

Informations de copyright

© 2020 Mahmoud et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Gastroenterology. 1997 Feb;112(2):594-642
pubmed: 9024315
J Clin Med Res. 2014 Apr;6(2):120-6
pubmed: 24578753
Ann Intern Med. 2008 Nov 4;149(9):627-37
pubmed: 18838716
Asian Pac J Cancer Prev. 2015;16(17):7425-30
pubmed: 26625738
Health Educ Q. 1992 Summer;19(2):157-75
pubmed: 1618625
Cancer Causes Control. 2011 Sep;22(9):1277-87
pubmed: 21710193
J Am Board Fam Med. 2012 Nov-Dec;25(6):782-91
pubmed: 23136316
Am J Prev Med. 1991 Mar-Apr;7(2):75-81
pubmed: 1910891
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Gen Intern Med. 2007 Dec;22(12):1681-8
pubmed: 17939007
Gastrointest Endosc. 2012 Jul;76(1):126-35
pubmed: 22726471
J Natl Med Assoc. 2007 Sep;99(9):1010-2
pubmed: 17913110
J Community Health. 2017 Feb;42(1):101-108
pubmed: 27516067
J Clin Oncol. 2004 Jul 1;22(13):2617-22
pubmed: 15226329
Am J Gastroenterol. 2001 Oct;96(10):3004-8
pubmed: 11693339
J Am Board Fam Pract. 1992 Mar-Apr;5(2):143-52
pubmed: 1575066

Auteurs

Mohamed Mahmoud (M)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Jessiya Parambil (J)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Mohammed Danjuma (M)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Ibrahim Abubeker (I)

Internal medicine, Rochester Regional Health Unit, USA.

Mostafa Najim (M)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Hafedh Ghazouani (H)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Dabia Al-Mohanadi (D)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Ahmed Al-Mohammed (A)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Anand Kartha (A)

Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

Mohamed A Yassin (MA)

Department of Medical Oncology, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

Classifications MeSH